Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Invasive Left Heart Catheterization for Patients Suspected Heart Failure With Preserved Ejection Fraction

NCT04505449 is registered in ClinicalTrials.gov with Samsung Medical Center as lead sponsor.

NCT NCT04505449
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04505449 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Invasive Left Heart Catheterization for Patients Suspected Heart Failure With Preserved Ejection Fraction
Lead sponsor
Samsung Medical Center
Phase
Observational
Overall status
Completed
Start date
December 13, 2019
Completion date
March 31, 2021
Enrollment
404 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure with preserved ejection fraction, left ventricular diastolic dysfunction